Cargando…
Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
INTRODUCTION: Cell count in induced sputum is a noninvasive biomarker to assess airway inflammation phenotypes. Accordingly, sputum cell counts are extensively used in the treatment of asthma and COPD. Nevertheless, the clinical application of sputum cell counts in patients with asthma–COPD overlap...
Autores principales: | Gao, Jie, Zhou, Wutie, Chen, Bida, Lin, Weiming, Wu, Sifang, Wu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602440/ https://www.ncbi.nlm.nih.gov/pubmed/28979112 http://dx.doi.org/10.2147/COPD.S142466 |
Ejemplares similares
-
Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016) -
Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients
por: Huang, Xiaolin, et al.
Publicado: (2019) -
Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]
Publicado: (2017) -
The Value of Inflammatory Biomarkers in Differentiating Asthma–COPD Overlap from COPD
por: Li, Meng, et al.
Publicado: (2020) -
Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations
por: Gao, Jie, et al.
Publicado: (2020)